Skip to content

Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma

Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma With Similar Structural Optic Nerve Damage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01488032
Enrollment
44
Registered
2011-12-08
Start date
2011-03-31
Completion date
2011-11-30
Last updated
2011-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Tension Glaucoma, Normal Tension Glaucoma

Brief summary

The purpose of the study is to prove if there is any difference in the nerve fiber layer between patients with normal- and high-tension-glaucoma with similar structural optic nerve head parameters.

Detailed description

It is till now not definitely clear whether normal- and high-tension glaucoma are different forms of the same disease and whether they have similar pathogenetic mechanisms. Spectral domain optical coherence tomography (SD-OCT) is supposed to objectively evaluate retinal nerve fiber layer (RNFL) thickness. The investigators propose a study to compare the RNFL in patients with normal- and high-tension-glaucoma. In order to exclude other possible differences,which could influence the results, only patients with similar structural optic nerve head damage in both groups will be compared.

Interventions

None listed

Sponsors

Technische Universität Dresden
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* persons over 18 years * men or women * with normal- and high-tension glaucoma

Exclusion criteria

* cataract * cloudy cornea and other conditions with bad visualisation quality of optic nerve head * optic nerve atrophy except glaucomatous

Design outcomes

Primary

MeasureTime frameDescription
RNFL in different segmentsup to 9 MonthsRNFL in upper, lower, temporal and nasal segments

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026